Peter P. Toth, MD, PhD, FASPC
Dr. Toth received his B.A. in Biochemistry from Princeton University and a Ph.D. in Biochemistry from Michigan State University. He graduated from Wayne State University School of Medicine and completed residency training at the University of Iowa Hospitals and Clinics. He is a member of Alpha Omega Alpha and Sigma Xi. He is a past president of the National Lipid Association and the American Board of Clinical Lipidology. He is the President of the American Society for Preventive Cardiology. He is a fellow of the American College of Cardiology, European Society of Cardiology, American Society of Preventive Cardiology, and the American Heart Association. Dr. Toth has authored and coauthored over 400 publications in medical and scientific journals and textbooks. He is Series Editor of Springer’s textbook collection in Contemporary Cardiology. He has edited and written 19 textbooks on various aspects of cardiovascular medicine. He has lectured on many topics in cardiovascular medicine throughout the world.
Martha Gulati, MD, MS, FACC, FAHA
Martha Gulati, MD, MS, FACC, FAHA, FASPC, FESC is the President-Elect of the American Society for Preventive Cardiology. She was a Professor of Medicine and the inaugural Chief of Cardiology at the University of Arizona. Previously, she held the Sarah Ross Soter Chair in Women’s Cardiovascular Health and was the Section Director for Women’s Cardiovascular Health and Preventive Cardiology at The Ohio State University until 2015. She is the author of the best-seller, “Saving Women’s Hearts”. She is the Editor-in-Chief of the American College of Cardiology “CardioSmart”, the patient education and empowerment initiative. She serves as the chair of the national chest pain guidelines that will be released in 2021.
Her exceptional commitment to the study of women and cardiac diseases has won her numerous awards and distinctions, including being named by Crain’s Chicago Business as one of Chicago’s Top 40 under 40. In 2011, she received the first CREDO (Coalition to Reduce Racial and Ethnic Disparities in Cardiovascular Outcomes) Award from the American College of Cardiology that was given to honor her contributions to improve cardiovascular healthcare of women patients. In 2012, she was awarded the National Red Dress Award for her efforts in raising awareness of heart disease in women and advancing research in this field. In 2019, she was chosen as the most influential woman in Arizona and received the 2019 American College of Cardiology’s Bernadine Healy Award for her leadership and accomplishment in the field of cardiovascular disease in women.
Dr. Gulati is passionate about the study of women and heart disease and prevention of heart disease. She is the principal investigator of the St. James Women Take Heart Project, a study examining cardiac risk factors in women, which set standards for women’s fitness levels and heart rate response to exercise in women. She also is a co-investigator on the Women Ischemic Syndrome Evaluation (WISE) and previously served as a co-investigator on the Women’s Health Initiative (WHI).
She is a member of numerous advisory boards and societies, including the American Heart Association (AHA), the American College of Cardiology and the American Society for Preventive Cardiology (ASPC). She serves on the board of the ASPC, the Phoenix chapter of the American Heart Association and served on the board of WomenHeart until 2020. She has published articles in peer-reviewed publications, including The New England Journal of Medicine, Circulation, and Journal of the American Medical Association (JAMA). Her research has been featured in hundreds of newspapers across the world, including The New York Times and USA Today. She has also been featured on Oprah and been feature on NBC Nightly News, CBS National News, The Today Show, Canada AM, in addition to many others. She recently was listed on the Marquis 2019 Who’s Who in America, Who’s Who in the World, and Who’s Who in American Women.
Dr. Gulati is Canadian and completed medical school at the University of Toronto, Canada. She went on to complete her internship, residency and cardiology fellowship at the University of Chicago. She received a Masters’ in Science at the University of Chicago and is a fellow of the American College of Cardiology and the American Heart Association. She is board certified in cardiovascular disease.
Michael Shapiro, DO, FASPC
Michael Shapiro is the inaugural Fred M. Parrish Professor of Cardiology and Molecular Medicine at Wake Forest University where he is on faculty in the Section of Cardiovascular Medicine. After completing a cardiology fellowship, Michael spent two additional years in a clinical and research fellowship focused on advanced cardiovascular imaging at Massachusetts General Hospital/Harvard Medical School. After training, he was on faculty in the Knight Cardiovascular Institute at Oregon Health & Science University. He served as Director of Atherosclerosis Imaging and Associate Director of the Center for Preventive Cardiology. In 2019, he transitioned to Wake Forest University where he serves as the Director of the Center for Prevention of Cardiovascular Disease and the Co-Director of the NIH T32 Cardiovascular Disease Epidemiology and Prevention Research Fellowship Program.
Michael's clinical interests focus on genetic and acquired disorders of cholesterol and triglycerides, atherosclerosis Imaging, genetic predisposition to early myocardial infarction, and cardiovascular risk assessment in apparently healthy individuals. Michael has published extensively in the areas of atherosclerosis imaging, lipid disorders, and preventive cardiology. His current investigative research focuses on PCSK9 physiology and its impact on lipoprotein metabolism. Other areas of research include metabolomics of atherosclerosis, development and validation of automated quantification of breast arterial calcification as a means to refine cardiovascular risk estimation in women, and implementation of machine learning algorithms to identify individuals with familial hypercholesterolemia. He is an established Multiethnic Study of Atherosclerosis and Diabetes Heart Study investigator. He also serves as a principal investigator on numerous clinical trials testing novel lipid modulating therapeutics. Michael is a member of numerous boards and national committees related to preventive cardiology, familial hypercholesterolemia, and lipid disorders.
David Moran, FASPC
Dr. Maron is Director of Preventive Cardiology. He is board certified in internal medicine, cardiovascular disease, and clinical lipidology. He was an undergraduate at Stanford, received his medical degree from University of Southern California, and completed his residency in internal medicine at UCLA. He completed a cardiology fellowship and a research fellowship in cardiovascular disease epidemiology and prevention at Stanford University as a Robert Wood Johnson Clinical Scholar. He was on the faculty at Vanderbilt for 20 years before returning to Stanford in 2014. His research is focused on primary and secondary prevention of coronary artery disease. He has extensive experience in multicenter clinical trials, serving as a member of the Executive Committee and Chair of the Optimal Medical Therapy Committee for the VA-funded COURAGE trial, and now as the PI and Co-Chair of the NHLBI-funded ISCHEMIA trial, and Co-Chair of the NHLBI-funded ISCHEMIA-CKD trial.
Amit Khera, MD, MSc, FACC, FAHA, FASPC
Dr. Khera is a President of the American Society for Preventive Cardiology and Professor of Medicine at the University of Texas, Southwestern Medical School in Dallas, Texas where he serves as Director of the Preventive Cardiology Section, and holder of the Dallas Heart Ball Chair in Hypertension and Heart Disease. His clinical and research interests include the primary and secondary prevention of coronary artery disease, focusing on risk assessment and risk factor modification in those with premature and familial disease.
Dr. Khera received his undergraduate degree in American History from the University of Pennsylvania, with magna cum laude honors. He obtained his medical degree from Baylor College of Medicine where he served as class president and was inducted into the Alpha Omega Alpha honor medical society. He completed an Internal Medicine Residency at Brigham and Women’s Hospital, Harvard Medical School, followed by a Cardiology Fellowship at the University of Texas, Southwestern Medical Center. He also completed his Masters degree in Epidemiology at the Harvard School of Public Health.
He has published over 100 articles in the field of preventive cardiology and has served on numerous local and national committee and leadership roles for the American Heart Association (AHA), American College of Cardiology, and American Society for Preventive Cardiology (ASPC).